Qiagen still on the acquisition trail, but looking for quality, not quantity
This article was originally published in Clinica
Executive Summary
Qiagen is bucking the global trend for belt-tightening, having dipped into its wallet to make strategic investments and acquire two companies outright. Madeleine Armstrong spoke to Jean-Pascal Viola, vice-president of corporate business development Americas, about Qiagen's acquisition strategy and what kind of companies it is looking for in future